PPB - Services

Complaints, Feedback and Enquiry

๐๐๐ ๐‚๐ก๐š๐ข๐ซ๐ฆ๐š๐ง ๐๐ฅ๐ž๐๐ ๐ž๐ฌ ๐’๐ญ๐ซ๐จ๐ง๐  ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐‹๐ž๐š๐๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐š๐ง๐ ๐‚๐จ๐ฆ๐ฆ๐ข๐ญ๐ฆ๐ž๐ง๐ญ ๐ญ๐จ ๐”๐‡๐‚ ๐š๐ง๐ ๐‹๐จ๐œ๐š๐ฅ ๐Œ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐ 

Nairobi, 26 November 2025 – The Chairman of the Pharmacy and Poisons Board (PPB), Dr. John Munyu, MBS, has reaffirmed the Boardโ€™s commitment to supporting the Ministry of Healthโ€™s agenda on Universal Health Coverage (UHC) and positioning Kenya as a competitive hub for pharmaceutical and vaccine manufacturing.

Speaking during the visit by the Cabinet Secretary for Health, Dr. Munyu underscored the Boardโ€™s determination to achieve World Health Organization (WHO) Maturity Level 3 by early next year, highlighting the need to increase staff, tighten points of entry, and strengthen regulatory systems. He emphasised that the Board is committed to building a strong, effective regulatory authority capable of delivering high standards in medicines and vaccine regulation.

โ€œWe are determined and ready to deliver Maturity Level 3 by early next year. PPB will continue to support the Ministryโ€™s agenda, strengthen oversight at points of entry, and ensure Kenya becomes a regional hub for pharmaceutical manufacturing,โ€ Dr. Munyu stated.

During the same session, PPB CEO Dr. Ahmed Mohamed assured that the Boardโ€™s management is fully aligned with the ministryโ€™s UHC vision.

Ends

Author

Public Relations

Leave a comment

Your email address will not be published. Required fields are marked *